Pathstone Holdings
MGNX icon

Pathstone Holdings’s MacroGenics MGNX Stock Holding History

Pathstone Holdings’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,281
Closed -$36.7K – 2341
2024
Q4 		$36.7K Sell
11,281
-4,613
-29% -$16.6K ﹤0.01% 2275
2024
Q3 		$52.3K Sell
15,894
-1,793
-10% -$6.99K ﹤0.01% 2286
2024
Q2 		$75.2K Sell
17,687
-11,474
-39% -$112K ﹤0.01% 2241
2024
Q1 		$429K Buy
29,161
+16,111
+123% +$244K ﹤0.01% 1754
2023
Q4 		$126K Buy
+13,050
New +$90.2K ﹤0.01% 2123

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathstone Holdings's MGNX Position: Q1 2025 in Review

Pathstone Holdings sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 11,281 shares — an estimated $36.7K sold.

Pathstone Holdings first reported a position in MGNX in Q4 2023 and held it in 5 quarters. The position peaked at $429K in Q1 2024. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • Pathstone Holdings reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 11,281 MacroGenics shares in Q1 2025, an estimated $36.7K.
  • Pathstone Holdings first reported a position in MacroGenics in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's MacroGenics position peaked at $429K in Q1 2024.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.